Join to View Full Profile
3811 Ohara StPittsburgh, PA 15213
Phone+1 412-624-1000
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bruce Pollock, MD is a psychiatrist in Pittsburgh, Pennsylvania.
Education & Training
University of Toronto Faculty of MedicineClass of 1979
Clinical Trials
- Serotonergic Pharmacotherapy for Agitation of Dementia Start of enrollment: 1995 Sep 01
- Treating Behavioral Disturbances in Individuals With Dementia Start of enrollment: 2000 Jan 01
- Antidepressant Medication Plus Donepezil for Treating Late-life Depression Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases.Erlan Sanchez, Gillian T Coughlan, Tim Wilkinson, Joel Ramirez, Saira Saeed Mirza
Neurology. 2025-04-08 - A Cross Sectional and Longitudinal Assessment of Neuropsychiatric Symptoms and Brain Functional Connectivity in Patients With Mild Cognitive Impairment, Cerebrovascula...Neda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, Sanjeev Kumar, Maria C Tartaglia
International Journal of Geriatric Psychiatry. 2025-04-01 - The Cognitive Profile of Older Adults With Treatment-Resistant Depression: An Analysis of the OPTIMUM Randomized Controlled Trial.Nicholas J Ainsworth, Hanadi Oughli, Helen Lavretsky, Daniel M Blumberger, Patrick J Brown
The American Journal of Geriatric Psychiatry. 2025-04-01
Press Mentions
Annual Meeting 2021 Preliminary Program GuideMarch 1st, 2021
Dementia Study SHOCK - Experts Warn Link to Alcohol Could Be WORSE Than ThoughtFebruary 27th, 2018
Alcohol Consumption Biggest Risk Factor for Dementia: StudyFebruary 23rd, 2018- Join now to see all
Grant Support
- Maintenance Therapies In Late-Life Depression-IiiNational Institute Of Mental Health2005–2008
- Geropsychopharmacology: Enhancing Benefit, Reducing RiskNational Institute Of Mental Health2002–2006
- Continuation Pharmacotherapy For Agitation Of DementiaNational Center For Research Resources2004–2005
- Atypical Antipsychotics: Determinants Of ConcentrationNational Institute Of Mental Health2001–2004
- Continuation Pharmacotherapy For Agitation Of DementiaNational Institute Of Mental Health2000–2004
- Core--Geriatric PsychopharmacologyNational Institute Of Mental Health2000–2002
- Serotonergic Pharmacotherapy For Agitation Of DementiaNational Center For Research Resources2000–2002
- Geropsychopharmacology--Enhancing Benefit, Reducing RiskNational Institute Of Mental Health1997–2001
- Core--Geriatric Clinical PsychopharmacologyNational Institute Of Mental Health1996–1999
- Serotonergic Pharmacotherapy For Agitation Of DementiaNational Institute Of Mental Health1995–1999
- Geriatric Neuroleptic Metabolism And ToxicityNational Institute Of Mental Health1992–1996
